Claris Injectables Limited is a global generic injectables pharmaceutical company.

Claris Injectables formulates, fills and finishes a broad portfolio of generic medicines with strengths in anesthesia and analgesics, critical care and renal medicines and anti-infectives—including antibiotics, antiprotozoals, antifungals and antivirals—in a variety of presentations including bags, vials and ampoules.

Claris Injectables has a 15-year track record of successfully launching new products around the world, with more than 50 products on-market today in more than 75 countries and a pipeline of more than 100 new products in development.